|
With UPS shares moving south, let's assess if the stock is a buy at current levels.
|
|
|
DOC's Q1 earnings are likely to have benefited from rising healthcare spending and the aging population. However, higher interest expenses may have hurt it.
|
|
|
High mortgage rates and ongoing affordability challenges in the housing market are likely to have impacted PHM's first-quarter performance.
|
|
|
Microchip leverages product innovation to navigate market challenges and support long-term growth despite broad-based weakness across multiple product lines.
|
|
|
Tesla may have started the race, but BYD is setting the pace. Does this Chinese EV giant now hold an upper hand in this high-stakes race for electric dominance?
|
|
|
PEP's Q1 results are expected to reflect persistent weakness in North America and QFNA segments, along with challenges from broader market volatility.
|
|
|
Ecolab announces a 5% U.S. trade surcharge to offset rising costs.
|
|
|
LVS' first-quarter performance is likely to have gained from the recovery of the Macao and Singapore markets and robust capital investment programs.
|
|
|
DHR's first-quarter earnings are likely to have been aided by strength in the Biotechnology segment. However, weakness in the Diagnostics and Life Sciences segments are expected to have hurt.
|
|
|
CRS's third-quarter fiscal 2025 results are likely to reflect the impacts of solid end-market demand, offset by supply-chain challenges.
|
|
Search Other Sites